Dossier
pharmaceutical innovation
Coverage of pharmaceutical innovation in the Nexus archive.
- ‘Systemic leap’: China’s drug innovation push yields bumper crop
In the first half of the year, over 80% of China's market drug approvals were domestically produced novel drugs, with 31 out of 38 total approvals. This reflects a 'leap' in pharmaceutical innovation, according to a government spokesman from the Ministry of Industry and Information Technology.
- ‘Systemic leap’: China’s drug innovation push yields bumper crop
China's pharmaceutical innovation has seen significant growth, with over 80% of drug approvals in the first half of the year being domestically produced. A total of 38 innovative drugs were approved, 31 of which were home-grown, according to a government official.